Paris, February 22, 2010 – Cellectis S.A. (Alternext: ALCLS), the French genome
engineering specialist, announces today that Allyson Holmes, PhD, Head of
External Scientific Relations will present Cellectis’ technologies and their
application in plants at the 2nd International Meeting on Plant DNA Repair and
Recombination that will take place in Asilomar, California, on March 2-5, 2010.
Dr Holmes will discuss the use of “Meganucleases for plant genome engineering”
at 11.25AM on March 5, 2010, during an oral session on Genetic Engineering.
About Cellectis S.A.
Cellectis is a pioneer in the field of genome engineering. The company designs and markets
innovative tools, meganucleases. These molecular scissors enable targeted modifications to DNA,
with applications in the research, biomanufacturing, agrobiotechnology and therapeutic sectors.
To date, Cellectis has formed over 20 academic research partnerships and has established more
than 50 agreements with pharmaceutical laboratories, seed producers and biotech companies
across the world. The company holds exclusive rights to a portfolio of over 260 patents granted or
pending.
Since 2007, Cellectis has been listed on the NYSE-Euronext Alternext market (code : ALCLS) in
Paris and has secured over €70 million in funding since inception.
More information at www.cellectis.com
